Comorbid eating disorders among women receiving treatment for substance use disorders: a systematic review and meta-analysis

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2022-10-04 DOI:10.1080/16066359.2022.2127692

Laura D. Robinson, Emma E. Walter, F. Deane, B. Larance

{"title":"Comorbid eating disorders among women receiving treatment for substance use disorders: a systematic review and meta-analysis","authors":"Laura D. Robinson, Emma E. Walter, F. Deane, B. Larance","doi":"10.1080/16066359.2022.2127692","DOIUrl":null,"url":null,"abstract":"Abstract Objective Comorbid eating disorders (EDs) and substance use disorders (SUDs) are common. Most research has explored substance use among individuals with an ED. Few studies describe the prevalence of EDs in samples of women with SUD who are attending treatment. This study is a systematic review and meta-analysis of the point and lifetime prevalence of comorbid ED among treatment-seeking female patients with SUD. Method Using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline, six databases were systematically searched to identify studies. Prevalence rates of EDs and/or ED behaviors and methodological factors were extracted from each eligible study. Risk of bias was assessed using the AXIS tool. Random-effects meta-analysis was used to pool prevalence estimates. The protocol is registered in PROSPERO. Results Full text reviews were conducted on 131 studies and 24 (N = 4767) met inclusion criteria. Point prevalence of disordered eating behaviors (DEBs) was 38.71% and lifetime prevalence 20.95%. The point prevalence of a diagnosed ED was 15.69% and lifetime prevalence was 15.67%. For any ED or disordered eating, the point prevalence was 29.99% and lifetime prevalence was 19.40%. Age was a significant negative moderator for point prevalence of AN which was 5.41%. Conclusions This review indicates that there is a high rate of women attending treatment for SUDs with comorbid EDs and/or DEBs. Implications for treatment approaches and suggestions for future research are provided.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2022-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/16066359.2022.2127692","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract Objective Comorbid eating disorders (EDs) and substance use disorders (SUDs) are common. Most research has explored substance use among individuals with an ED. Few studies describe the prevalence of EDs in samples of women with SUD who are attending treatment. This study is a systematic review and meta-analysis of the point and lifetime prevalence of comorbid ED among treatment-seeking female patients with SUD. Method Using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guideline, six databases were systematically searched to identify studies. Prevalence rates of EDs and/or ED behaviors and methodological factors were extracted from each eligible study. Risk of bias was assessed using the AXIS tool. Random-effects meta-analysis was used to pool prevalence estimates. The protocol is registered in PROSPERO. Results Full text reviews were conducted on 131 studies and 24 (N = 4767) met inclusion criteria. Point prevalence of disordered eating behaviors (DEBs) was 38.71% and lifetime prevalence 20.95%. The point prevalence of a diagnosed ED was 15.69% and lifetime prevalence was 15.67%. For any ED or disordered eating, the point prevalence was 29.99% and lifetime prevalence was 19.40%. Age was a significant negative moderator for point prevalence of AN which was 5.41%. Conclusions This review indicates that there is a high rate of women attending treatment for SUDs with comorbid EDs and/or DEBs. Implications for treatment approaches and suggestions for future research are provided.

查看原文本刊更多论文

接受药物使用障碍治疗的女性共病性饮食障碍:系统回顾和荟萃分析

摘要目的共病性饮食障碍(EDs)和物质使用障碍(sud)较为常见。大多数研究都探讨了ED患者的药物使用情况。很少有研究描述了在接受治疗的ED患者样本中ED的患病率。本研究对寻求治疗的女性SUD患者合并症ED的时点和终生患病率进行了系统回顾和荟萃分析。方法采用系统评价和荟萃分析首选报告项目(PRISMA)指南，系统检索6个数据库以确定研究。从每个符合条件的研究中提取ED的患病率和/或ED行为和方法学因素。使用轴偏差的风险评估工具。随机效应荟萃分析用于汇总患病率估计。该协议在PROSPERO中注册。结果131项研究进行了全文综述，其中24项(N = 4767)符合纳入标准。饮食失调的点患病率为38.71%，终生患病率为20.95%。诊断为ED的点患病率为15.69%，终生患病率为15.67%。对于任何ED或饮食失调，点患病率为29.99%，终生患病率为19.40%。年龄是AN点患病率的显著负向调节因子，为5.41%。结论:本综述表明，女性接受SUDs合并ed和/或DEBs治疗的比例很高。对治疗方法和未来研究提出建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.